166 related articles for article (PubMed ID: 35016695)
1. The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019.
Yao Y; Lin X; Li F; Jin J; Wang H
Biomed Eng Online; 2022 Jan; 21(1):4. PubMed ID: 35016695
[TBL] [Abstract][Full Text] [Related]
2. The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017.
Yi M; Li A; Zhou L; Chu Q; Song Y; Wu K
J Hematol Oncol; 2020 Jun; 13(1):72. PubMed ID: 32513227
[TBL] [Abstract][Full Text] [Related]
3. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
GBD 2015 Tobacco Collaborators
Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
[TBL] [Abstract][Full Text] [Related]
4. Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study.
Ou Y; Long Y; Ji L; Zhan Y; Qiao T; Wang X; Chen H; Cheng Y
Front Oncol; 2022; 12():840616. PubMed ID: 35359356
[TBL] [Abstract][Full Text] [Related]
5. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
[TBL] [Abstract][Full Text] [Related]
6. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Oesophageal Cancer Collaborators
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
[TBL] [Abstract][Full Text] [Related]
7. Global disease burden and trends of leukemia attributable to occupational risk from 1990 to 2019: An observational trend study.
Shi Y; Chen C; Huang Y; Xu Y; Xu D; Shen H; Ye X; Jin J; Tong H; Yu Y; Tang X; Li A; Cui D; Xie W
Front Public Health; 2022; 10():1015861. PubMed ID: 36452945
[TBL] [Abstract][Full Text] [Related]
8. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.
Liu J; Wu Q; Hao Y; Jiao M; Wang X; Jiang S; Han L
Hum Reprod; 2021 Mar; 36(4):1108-1119. PubMed ID: 33501984
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.
Deng Y; Zhao P; Zhou L; Xiang D; Hu J; Liu Y; Ruan J; Ye X; Zheng Y; Yao J; Zhai Z; Wang S; Yang S; Wu Y; Li N; Xu P; Zhang D; Kang H; Lyu J; Dai Z
J Hematol Oncol; 2020 Jul; 13(1):98. PubMed ID: 32690044
[TBL] [Abstract][Full Text] [Related]
10. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
GBD 2017 Stomach Cancer Collaborators
Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):42-54. PubMed ID: 31648970
[TBL] [Abstract][Full Text] [Related]
11. Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study.
Ning L; Hu C; Lu P; Que Y; Zhu X; Li D
Exp Hematol Oncol; 2020 Nov; 9(1):29. PubMed ID: 33292593
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, Incidence, and Years Lived With Disability Due to Gout and Its Attributable Risk Factors for 195 Countries and Territories 1990-2017: A Systematic Analysis of the Global Burden of Disease Study 2017.
Safiri S; Kolahi AA; Cross M; Carson-Chahhoud K; Hoy D; Almasi-Hashiani A; Sepidarkish M; Ashrafi-Asgarabad A; Moradi-Lakeh M; Mansournia MA; Kaufman JS; Collins G; Woolf AD; March L; Smith E
Arthritis Rheumatol; 2020 Nov; 72(11):1916-1927. PubMed ID: 32755051
[TBL] [Abstract][Full Text] [Related]
13. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Respiratory Tract Cancers Collaborators
Lancet Respir Med; 2021 Sep; 9(9):1030-1049. PubMed ID: 34411511
[TBL] [Abstract][Full Text] [Related]
14. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.
Safiri S; Kolahi AA; Naghavi M;
BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34844997
[TBL] [Abstract][Full Text] [Related]
15. Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990-2019: Estimation based on Global Burden of Disease Study 2019.
Hu Y; Zhang X; Zhang A; Hou Y; Liu Y; Li Q; Wang Y; Yu Y; Hou M; Peng J; Yang X; Xu S
Hematol Oncol; 2022 Feb; 40(1):92-104. PubMed ID: 34664286
[TBL] [Abstract][Full Text] [Related]
16. Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990-2017.
Lin X; Xu Y; Xu J; Pan X; Song X; Shan L; Zhao Y; Shan PF
Endocrine; 2020 Aug; 69(2):310-320. PubMed ID: 32488838
[TBL] [Abstract][Full Text] [Related]
17. The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030.
Du M; Chen W; Liu K; Wang L; Hu Y; Mao Y; Sun X; Luo Y; Shi J; Shao K; Huang H; Ye D
J Oncol; 2022; 2022():1612702. PubMed ID: 35509847
[TBL] [Abstract][Full Text] [Related]
18. Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study.
Lin X; Wang J; Huang X; Wang H; Li F; Ye W; Huang S; Pan J; Ling Q; Wei W; Mao S; Qian Y; Jin J; Huang J
Aging (Albany NY); 2021 Apr; 13(7):10468-10489. PubMed ID: 33820874
[TBL] [Abstract][Full Text] [Related]
19. Global, regional, and national burden of ovarian cancer and the attributable risk factors in all 194 countries and territories during 2007-2017: A systematic analysis of the Global Burden of Disease Study 2017.
Yang D; Huang H; Ruan T; Yang H; Hu J; Xu S; Ling S; Yu Y
J Obstet Gynaecol Res; 2021 Dec; 47(12):4389-4402. PubMed ID: 34674356
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Global Burden of Disease study highlights the trends in death and disability-adjusted life years of leukemia from 1990 to 2017.
Ou Z; Yu D; Liang Y; He W; Li Y; Zhang M; You F; He H; Chen Q
Cancer Commun (Lond); 2020 Nov; 40(11):598-610. PubMed ID: 32936522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
